Physician profile
Fritz Breckner
NPI 1639465669
$10,731.47
in general payments reported to CMS, 2019-2025
15 companies · $604 in 2025
The $604 reported for 2025 was more than what 93% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.27 · 2023: $9,044 · 2024: $1,070 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $6,000 · Food and Beverage: $2,878 · Travel and Lodging: $1,073 · Education: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $6,000.00 |
| Food and Beverage | $2,878.39 |
| Travel and Lodging | $1,072.89 |
| Education | $766.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,038.95 | 2023-2024 | Synchromedii, Vanta Adaptivestim, Intellis Adaptivestim |
| Abbott Laboratories | $2,621.14 | 2023-2025 | Eterna, Proclaim |
| Nevro Corp. | $961.38 | 2023 | Omnia, Senza |
| Stryker Corporation | $202.00 | 2025 | Mild Device Kit, Optablate, Spinejack |
| Nalu Medical, INC. | $174.97 | 2023 | Nalu Neurostimulation System |
| Biotronik Nro, INC. | $144.60 | 2024 | Prospera |
| Boston Scientific Corporation | $133.38 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $95.83 | 2025 | |
| Mml US, INC. | $93.19 | 2024 | Reactiv8 |
| Saluda Medical Americas, INC. | $88.18 | 2024 | Evoke |
| Merz Pharmaceuticals, LLC | $69.06 | 2025 | Xeomin |
| Pacira Pharmaceuticals Incorporated | $38.69 | 2024 | Iovera |
| Vertos Medical, INC. | $36.37 | 2024 | Mild Device Kit |
| Globus Medical, INC. | $20.46 | 2025 | Vyrsa V1 |
| Janssen Pharmaceuticals, INC | $13.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fritz Breckner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.